According to the ‘Perugia model’, the D-R KIR-ligand incompatibility leads to stronger NK cell mediated graft versus leukemia (GVL) effect resulting in protection from leukemia relapse [16, 17]. The gene discussed is KIR3DL1; the disease is leukemia.